In an effort to stem the smoldering epidemic of hepatitis C, the Centers for Disease Control and Prevention is proposing today that all Baby Boomers—anyone born between 1945 and 1965—have a one-time test for hepatitis C. This widespread but often silent disease can lead to liver damage, and even death.
An experimental approach to virtual colonoscopy could eliminate the unpleasant day-before bowel prep that keeps many people from having this potentially life-saving test. Virtual colonoscopy uses computed tomography (CT) scanning with X-rays, instead of a scope, to check the colon for cancers and precancerous polyps. Earlier version have required bowel cleaning, just like regular colonoscopy. A Harvard-based team led by Dr. Michael Zalis uses sophisticated computer software to make stool in the colon disappear. It’s a little like Photoshopping blemishes from still photos. “Laxative-free CT colonography has the potential to reach some of the unscreened population and save lives,” says Dr. Zalis, an associate professor of radiology at MGH and director of CT colonography at MGH Imaging.
Surviving cancer was once a challenging achievement. Today, more than 12 million Americans are cancer survivors, and many live long after their diagnoses. New guidelines from the American Cancer Society (ACS) offer them science-based advice for eating better and staying active—two keys to healthy living for cancer survivors and everyone else. The report, called Nutrition and Physical Activity Guidelines for Cancer Survivors, is available for free from the ACS website. The guidelines provide specific advice for survivors of a variety of major cancers: prostate, colorectal, lung, breast, ovarian, endometrial, upper GI, head and neck, and hematologic. They urge cancer survivors to maintain a healthy weight, avoid inactivity and return to normal daily activities as soon as possible following diagnosis, eventually aim to exercise at least 150 minutes per week, and follow an eating pattern that is rich in vegetables, fruits, and whole grains.
Warren Buffett may be the second richest man in America, but he appears to be getting the poorest medical advice. Buffett announced to Berkshire Hathaway shareholders last week that he has early stage prostate cancer that “is not remotely life-threatening or even debilitating in any meaningful way.” If Buffett’s cancer had been detected because he […]
A trio of new studies from the University of Oxford suggests that aspirin is worth testing as a simple way to help prevent cancer. But these are preliminary findings, and you shouldn’t start taking an aspirin a day without having a conversion with your doctor. That’s because aspirin has side effects that could offset any possible cancer-fighting benefit, including stomach upset, gastrointestinal bleeding and hemorrhagic stroke (bleeding in the brain). The Oxford studies couldn’t determine cause and effect. The only way to tally up the true balance of benefits and risks of aspirin for cancer prevention is with trials specifically designed to do that. Several are underway or in the planning stages. But you can work to prevent cancer right now by avoiding tobacco in all its forms, exercising, and making other healthy changes.
Many people have trouble quitting smoking even after learning they have cancer, according to a new study from Harvard-affiliated Massachusetts General Hospital. Five months after learning they had cancer, just over one-third (37%) of smokers diagnosed with lung cancer and two-thirds (66%) of those with colorectal cancer were still smoking. The results underscore how difficult it can be to quit smoking. A diagnosis of cancer can be a powerful motivator, but it isn’t always enough—extra help is often needed to quit. Kicking a smoking habit is good for health anytime. It is even more important after a diagnosis of cancer.
Many prostate cancers grow very slowly and never escape the prostate. They cause no symptoms, and never threaten health or life. Yet almost 90% of men told they have prostate cancer opt for immediate treatment with surgery or radiation therapy—which often cause trouble getting or keeping an erection and an assortment of urinary problems. Yesterday, a panel of experts convened by the National Institutes of Health recommended that many men with localized, low-risk prostate cancer be closely monitored, and that treatment be delayed until there was evidence that the disease was progressing.
The death of Kara Kennedy, the only daughter of the late Senator Edward M. Kennedy, at age 51 from an apparent heart attack while exercising offers a reminder of the possible long-term effects of cancer and its treatment. In 2002, Kennedy was diagnosed with lung cancer. After having part of her lung removed, she underwent chemotherapy and radiation therapy. She lived for another nine years, in apparently good health. One of the hazards of some cancer survivors face is that the treatments used to fight cancer—drugs, radiation, and hormones—sometimes damage the heart and arteries.
Is sunlight addictive? That provocative idea was raised by Dr. David Fisher, chief of dermatology at Massachusetts General Hospital in Boston, in a presentation at Harvard Medical School. He cited new evidence suggesting that being in the sun stimulates the so-called “pleasure center” in the brain and releases a rush of feel-good chemicals like endorphins, much as happens with addictive substances or activities. Why? Humans need vitamin D to survive. Once upon a time, it came mainly from skin—skin exposed to sunlight makes vitamin D. So the feelings of pleasure we get from sunlight may be part of a survival mechanism to get us the vitamin D we need.
Routinely checking smokers for early signs of lung cancer hasn’t translated into fewer deaths. New results from the National Lung Screening Trial indicate that yearly low-dose CT scans can reduce the death rate from lung cancer by 20%, which could save up to 30,000 lives a year. Despite the encouraging results, it is too early to recommend that heavy smokers immediately begin getting yearly CT scans for lung cancer. The physical, emotional, and monetary costs of saving these lives with yearly screening would be enormous. Researchers must look carefully at the financial and personal costs to determine who, if anyone, might benefit most from lung cancer screening.